A dominant interfering mutant of FADD/MORT1 enhances deletion of autoreactive thymocytes and inhibits proliferation of mature T lymphocytes

EMBO Journal

Volumn 17, Issue 3, 1998, Pages 706-718

  Newton, Kim ^a   Harris, Alan W ^a   Bath, Mary L ^a   Smith, Kenneth G C ^a,b   Strasser, Andreas ^a  

^a ROYAL MELBOURNE HOSPITAL   (Australia)

^b UNIVERSITY OF CAMBRIDGE   (United Kingdom)

Author keywords

APO 1; Apoptosis; CD95; FADD MORT1; Fas; T lymphocytes

Indexed keywords

CELL PROTEIN; MUTANT PROTEIN; TUMOR NECROSIS FACTOR RECEPTOR;

ANIMAL CELL; APOPTOSIS; ARTICLE; CELL DEATH; CELL DIFFERENTIATION; CELL SURVIVAL; CONTROLLED STUDY; LYMPHOCYTE PROLIFERATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN PROTEIN INTERACTION; T LYMPHOCYTE; T LYMPHOCYTE ACTIVATION; THYMOCYTE;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; ANIMALS; ANTIGENS, CD95; APOPTOSIS; CARRIER PROTEINS; CELL DIVISION; CELLS, CULTURED; CLONE CELLS; FAS-ASSOCIATED DEATH DOMAIN PROTEIN; GENES, DOMINANT; HUMANS; LYMPHOCYTE ACTIVATION; MICE; MICE, INBRED C57BL; MICE, INBRED MRL LPR; MICE, TRANSGENIC; MITOGENS; MUTATION; SERPINS; SUPERANTIGENS; T-LYMPHOCYTES; THYMUS GLAND; TRANSDUCTION, GENETIC;

ANIMALIA; MUS MUSCULUS;

EID: 0032472916     PISSN: 02614189     EISSN: None     Source Type: Journal    
DOI: 10.1093/emboj/17.3.706     Document Type: Article

References (72)

1. Adachi, M., Suematsu, S., Kondo, T., Ogasawara, J., Tanaka, T., Yoshida, N. and Nagata, S. (1995) Targeted mutation in the Fas gene causes hyperplasia in peripheral lymphoid organs and liver. Nature Genet., 11, 294-300.
2. Aggarwal, B.B., Singh, S., LaPushin, R. and Totpal, K. (1995) Fas antigen signals proliferation of normal human diploid fibroblast and its mechanism is different from tumour necrosis factor receptor. FEBS Lett., 364, 5-8.
3. Alderson, M., Armitage, R.J., Maraskovsky, E., Tough, T.W., Roux, E., Schooley, K., Ramsdell, F. and Lynch, D.H. (1993) Fas transduces activation signals in normal human T lymphocytes. J. Exp. Med., 178, 2231-2235.
4. Alderson, M.R. et al. (1995) Fas ligand mediates activation-induced cell death in human T lymphocytes. J. Exp. Med., 181, 71-77.
5. Amakawa, R. et al. (1996) Impaired negative selection of T cells in Hodgkin's Disease antigen CD30-deficient mice. Cell, 84, 551-562.
6. Boldin, M.P., Varfolomeev, E.E., Pancer, Z., Mett, I.L., Camonis, J.H. and Wallach, D. (1995) A novel protein that interacts with the death domain of Fas/APO1 contains a sequence motif related to the death domain. J. Biol. Chem., 270, 7795-7798.
7. Boldin, M.P., Goncharov, T.M, Goltsev, Y.V. and Wallach, D. (1996) Involvement of MACH, a novel MORT1/FADD interacting protease, in Fas/APO-1-and TNF receptor-induced cell death. Cell, 85, 803-815.
8. Brunner, T. et al. (1995) Cell-autonomous Fas (CD95)/Fas-ligand interaction mediates activation-induced apoptosis in T-cell hybridomas. Nature, 373, 441-444.
9. Chaffin, K.E., Beals, C.R., Wilkie, T.M., Forbush, K.A., Simon, M.I. and Perlmutter, R.M. (1990) Dissection of thymocyte signaling pathways by in vivo expression of pertussis toxin ADP-ribosyltransferase. EMBO J., 9, 3821-3829.
10. Chinnaiyan, A.M., O'Rourke, K., Tewari, M. and Dixit, V.M. (1995) FADD, a novel death domain-containing protein, interacts with the death domain of Fas and initiates apoptosis. Cell, 81, 505-512.
11. Chinnaiyan, A.M. et al. (1996a) Signal transduction by DR3, a death domain-containing receptor related to TNFR-1 and CD95. Science, 274, 990-992.
12. Chinnaiyan, A.M. et al (1996b) FADD/MORT1 is a common mediator of CD95 (Fas/APO-1) and tumor necrosis factor receptor-induced apoptosis. J. Biol. Chem., 271, 4961-4965.
13. Clayton, L.K., Ghendler, Y., Mizoguchi, E., Patch, R.J., Ocain, T.D., Orth, K., Bhan, A.K., Dixit, V.M. and Reinherz, E.L. (1997) T-cell receptor ligation by peptide/MHC induces activation of a caspase in immature thymocytes: the molecular basis of negative selection. EMBO J., 16, 2282-2293.
14. Cohen, P.L. and Eisenberg, R.A. (1993) The lpr and gld genes in systemic autoimmunity: life and death in the Fas lane. Immunol. Today, 13, 427-428.
15. Dhein, J., Walczak, H., Baumler, C., Debatin, K.-M. and Krammer, P.H. (1995) Autocrine T-cell suicide mediated by APO-1/(Fas/CD95). Nature, 373, 438-441.
16. Duan, H. and Dixit, V.M. (1997) RAIDD is a new 'death' adaptor molecule. Nature, 385, 86-89.
17. Erickson, S.L. et al. (1994) Decreased sensitivity to tumour-necrosis factor but normal T-cell development in TNF receptor-2-deficient mice. Nature, 372, 560-563.
18. Foy, T.M. et al. (1995) An essential role for gp39, the ligand for CD40, in thymic selection. J. Exp. Med., 182, 1377-1388.
19. Grell, M. et al. (1995). The transmembrane form of tumor necrosis factor is the prime activating ligand of the 80 kDa tumor necrosis factor receptor. Cell, 83, 793-802.
20. Hsu, H., Xiong, J. and Goeddel, D.V. (1995) The TNF receptor 1-associated protein TRADD signals cell death and NF-κB activation. Cell, 81, 495-504.
21. Hsu, H., Huang, J., Shu, H.-B., Baichwal, V. and Goeddel, D.V. (1996a) TNF-dependent recruitment of the protein kinase RIP to the TNF receptor-1 signaling complex. Immunity, 4, 387-396.
22. Hsu, H., Shu, H.-B., Pan, M.-G. and Goeddel, D.V. (1996b) TRADD-TRAF2 and TRADD-FADD interactions define two distinct TNF Receptor 1 signal transduction pathways. Cell, 84, 299-308.
23. xL and adenovirus protein E1B19kD are functionally equivalent in their ability to inhibit cell death. Oncogene, 14, 405-414.
24. Irmler, M. et al. (1997) Inhibition of death receptor signals by cellular FLIP. Nature, 388, 190-194.
25. Itoh, N. and Nagata, S. (1993) A novel protein domain required for apoptosis. J. Biol. Chem., 268, 10932-10937.
26. Jacobson, M.D., Weil, M. and Raff, M.C. (1997) Programmed cell death in animal development. Cell, 88, 347-354.
27. Ju, S.-T., Panka, D.J., Cui, H., Ettinger, R., El-Khatib, M., Sherr, D.H., Stanger, B.Z. and Marshak-Rothstein, A. (1995) Fas(CD95)/FasL interactions required for programmed cell death after T-cell activation. Nature, 373, 444-448.
28. Kaplan, D.R. and Miller, F.D. (1997) Signal transduction by the neurotrophin receptors. Curr. Opin. Cell Biol., 9, 213-221.
29. Klas, C., Debatin, K.-M., Jonker, R.R. and Krammer, P.H. (1993) Activation interferes with the APO-1 pathway in mature human T cells. Int. Immunol., 5, 625-630.
30. Kruppa, G., Thoma, B., Machleidt, T., Wiegmann, K. and Kronke, M. (1992) Inhibition of tumor necrosis factor (TNF)-mediated NF-κB activation by selective blockade of the human 55-kDa TNF receptor. J. Immunol., 148, 3152-3157.
31. Mackay, F., Rothe, J., Bluethmann, H., Loetscher, H. and Lesslauer, W. (1994) Differential responses of fibroblasts from wild-type and TNF-R55-deficient mice to mouse and human TNF-α activation. J. Immunol., 153, 5274-5284.
32. Mapara, M.Y., Bargou, R., Zugck, C., Dohner, H., Ustaoglu, F., Jonker, R.R., Krammer, P.H. and Dorken, B. (1993) APO-1 mediated apoptosis or proliferation in human chronic B lymphocytic leukemia: correlation with bcl-2 oncogene expression. Eur. J. Immunol., 23, 702-708.
33. McCusker, J., Dawson, M.T., Noone, D., Gannon, F. and Smith, T. (1992) Improved method for direct PCR amplification from whole blood. Nucleic Acids Res., 20, 6747.
34. + thymocytes in vitro is independent of the CD95 (APO-1/Fas) ligand. Eur. J. Immunol., 25, 2996-2999.
35. 1o thymocytes in vivo. Science, 250, 1720-1723.
36. Muzio, M. et al. (1996). FLICE, a novel FADD homologous ICE/CED-3-like protease, is recruited to the CD95 (Fas/Apo-1) death-inducing signaling complex. Cell, 85, 817-827.
37. Nagata, S. (1997) Apoptosis by death factor. Cell, 88, 355-365.
38. + thymocytes by the anti-Fas antibody. J. Exp. Med., 181, 485-491.
39. Owen-Schaub, L.B., Yonehara, S., Crump, W.L.I. and Grimm, E.A. (1992) DNA fragmentation and cell death is selectively triggered in activated human lymphocytes by Fas antigen engagement. Cell. Immunol., 140, 197-205.
40. Owen-Schaub, L.B., Radinsky, R., Kruzel, E., Berry, K. and Yonehara, S. (1994) Anti-Fas on nonhematopoietic tumors: levels of Fas/APO-1 and bcl-2 are not predictive of biological responsiveness. Cancer Res., 54, 1580-1586.
41. Pan, G., O'Rourke, K., Chinnaiyan, A.M., Gentz, R., Ebner, R., Ni, J. and Dixit, V.M. (1997) The receptor for the cytotoxic ligand TRAIL. Science, 276, 111-113.
42. Pfeffer, K. et al. (1993) Mice deficient for the 55 kDa tumor necrosis factor receptor are resistant to endotoxic shock, yet succumb to L. monocytogenes infection. Cell, 73, 457-467.
43. Prasad, K.V.S., Ao, Z., Yoon, Y., Wu, M.X., Rizk, M., Jacquot, S. and Schlossman, S.F. (1997) CD27, a member of the tumor necrosis factor receptor family, induces apoptosis and binds to Siva, a proapoptotic protein. Proc. Natl Acad. Sci. USA, 94, 6346-6351.
44. Pullen, A.M., Marrack, P. and Kappler, J.W. (1988) The T-cell repertoire is heavily influenced by tolerance to polymorphic self-antigens. Nature, 335, 796-801.
45. Ray, C.A., Black, R.A., Kronheim, S.R., Greenstreet, G.S. and Pickup, D.J. (1992) Viral inhibition of inflammation: cowpox virus encodes an inhibitor of the interleukin-1β converting enzyme. Cell, 69, 597-604.
46. Rothe, J. et al. (1993) Mice lacking the tumour necrosis factor receptor 1 are resistant to TNF-mediated toxicity but highly susceptible to infection by Listeria monocytogenes. Nature, 364, 798-802.
47. Rothe, M., Wong, S.C., Henzel, W.J. and Goeddel, D.V. (1994) A novel family of putative signal transducers associated with the cytoplasmic domain of the 75 kDa tumor necrosis factor receptor. Cell, 78, 681-692.
48. Sentman, C.L., Shutter, J.R., Hockenbery, D., Kanagawa, O. and Korsmeyer, S.J. (1991) bcl-2 inhibits multiple forms of apoptosis but not negative selection in thymocytes. Cell, 67, 879-888.
49. Shlomchik, M.J., Madaio, M.P., Ni, D., Trounstein, M. and Huszar, D. (1994) The role of B cells in lpr/lpr-mauced autoimmunity. J. Exp. Med., 180, 1295-1306.
50. Sidman, C.L., Marshall, J.D. and von Boehmer, H. (1992.) Transgenic T cell receptor interactions in the lymphoproliferative and autoimmune syndromes of lpr and gld mutant mice. Eur. J. Immunol., 22, 499-504.
51. Smith, C.A., Williams, G.T., Kingston, R., Jenkinson, E.J. and Owen, J.J.T. (1989) Antibodies to CD3/T-cell receptor complex induce death by apoptosis in immature T cells in thymic cultures. Nature, 337, 181-184.
52. Smith, D.J., McGuire, M.J., Tocci, M.J. and Thiele, D.L. (1997) IL-Iβ Convertase (ICE) does not play a requisite role in apoptosis induced in T lymphoblasts by Fas-dependent or Fas-independent CTL effector mechanisms. J. Immunol., 158, 163-170.
53. Smith, K.G.C., Strasser, A. and Vaux, D.L. (1996) CrmA expression in T lymphocytes of transgenic mice inhibits CD95 (Fas/APO-1)-transduced apoptosis, but does not cause lymphadenopathy or autoimmune disease. EMBO J., 15, 5167-5176.
54. Speiser, D.E., Sebzda, E., Ohteki, T., Bachmann, M.F., Pfeffer, K., Mak, T.W. and Ohashi, P.S. (1996) Tumor necrosis factor receptor p55 mediates deletion of peripheral cytotoxic T lymphocytes in vivo. Eur. J. Immunol., 26, 3055-3060.
55. Stanger, B.Z., Leder, P., Lee, T.-H., Kim, E. and Seed, B. (1995) RIP: a novel protein containing a death domain that interacts with Fas/APO-1 (CD95) in yeast and causes cell death. Cell, 81, 513-523.
56. Strasser, A. (1995) Life and death during lymphocyte development and function: evidence for two distinct killing mechanisms. Curr. Opin. Immunol., 7, 228-234.
57. Strasser, A., Harris, A.W. and Cory, S. (1991) Bcl-2 transgene inhibits T cell death and perturbs thymic self-censorship. Cell, 67, 889-899.
58. Strasser, A., Harris, A.W., Von Boehmer, H. and Cory, S. (1994) Positive and negative selection of T cells in T cell receptor transgenic mice expressing a bcl-2 transgene. Proc. Natl Acad. Sci. USA, 91, 1376-1380.
59. Strasser, A., Harris, A.W., Huang, D.C.S., Krammer, P.H. and Cory, S. (1995) Bcl-2 and Fas/APO-1 regulate distinct pathways to lymphocyte apoptosis. EMBO J., 14, 6136-6147.
60. Suda, T., Tanaka, M., Miwa, K. and Nagata, S. (1996) Apoptosis of mouse naive T cells induced by recombinant soluble Fas ligand and activation-induced resistance to Fas ligand. J. Immunol., 157, 3918-3924.
61. Surh, C.D. and Sprent, J. (1994) T-cell apoptosis detected in situ during positive and negative selection in the thymus. Nature, 372, 100-103.
62. Sytwu, H.-K., Liblau, R.S. and McDevitt, H.O. (1996) The roles of Fas/ APO-1 (CD95) and TNF in antigen-induced programmed cell death in T cell receptor transgenic mice. Immunity, 5, 17-30.
63. Tartaglia, L.A., Ayres, T.M., Wong, G.H.W. and Goeddel, D.V. (1993) A novel domain within the 55 kDa TNF receptor signals cell death. Cell, 74, 845-853.
64. Thilenius, A.R.B., Braun, K. and Russell, J.H. (1997) Agonist antibody and Fas ligand mediate different sensitivity to death in the signaling pathways of Fas and cytoplasmic mutants. Eur. J. Immunol., 27, 1108-1114.
65. Vincenz, C. and Dixit, V.M. (1997) Fas-associated death domain protein interleukin-1β-converting enzyme 2 (FLICE2), an ICE/Ced-3 homologue, is proximally involved in CD95-and p55-mediated death signaling. J. Biol. Chem., 272, 6578-6583.
66. von Boehmer, H. (1990) Developmental biology of T cells in T cell-receptor transgenic mice. Annu. Rev. Immunol., 8, 531-556.
67. Walczak, H. et al. (1997) TRAIL-R2: a novel apoptosis-mediating receptor for TRAIL. EMBO J., 16, 5386-5397.
68. Wallach, D., Boldin, M., Goncharov, T., Goltsev, Y., Mett, I., Malinin, N., Adar, R., Kovalenko, A. and Varfolomeev, E. (1996) Exploring cell death mechanisms by analyzing signaling cascades of the TNF/NGF receptor family. Behring Inst. Mitteilungen, 97, 144-155.
69. Wiley, S.R. et al. (1995) Identification and characterization of a new member of the TNF family that induces apoptosis. Immunity, 3, 673-682.
70. Yamada, Y., Kirillova, I., Peschon, J.J. and Fausto, N. (1997) Initiation of liver growth by tumor necrosis factor: deficient liver regeneration in mice lacking type I tumor necrosis factor receptor. Proc. Natl Acad. Sci. USA, 94, 1441-1446.
71. Yang, X., Khosravi-Far, R., Chang, H.Y. and Baltimore, D. (1997) Daxx, a novel Fas-binding protein that activates JNK and apoptosis. Cell, 89, 1067-1076.
72. Zhou, Q., Snipas, S., Orth, K., Muzio, M., Dixit, V.M. and Salvesen, G.S. (1997) Target protease specificity of the viral serpin CrmA. J. Biol. Chem., 272, 7797-7800.